Annual EBITDA
-$2.75 M
-$859.60 K-45.36%
December 31, 2023
Summary
- As of March 11, 2025, GDTC annual EBITDA is -$2.75 million, with the most recent change of -$859.60 thousand (-45.36%) on December 31, 2023.
- During the last 3 years, GDTC annual EBITDA has fallen by -$1.64 million (-147.02%).
- GDTC annual EBITDA is now -147.02% below its all-time high of -$1.12 million, reached on December 1, 2020.
Performance
GDTC EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
GDTC EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -45.4% | - | - |
| 3 y3 years | -147.0% | - | - |
| 5 y5 years | -147.0% | - | - |
GDTC EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -130.7% | at low | ||||
| 5 y | 5-year | -147.0% | at low | ||||
| alltime | all time | -147.0% | at low |
CytoMed Therapeutics Limited EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$2.75 M(+45.4%) | - | - |
| Dec 2022 | -$1.90 M(+58.7%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$1.19 M(+7.1%) | - | - |
| Dec 2020 | -$1.12 M | - | - |
FAQ
- What is CytoMed Therapeutics Limited annual EBITDA?
- What is the all time high annual EBITDA for CytoMed Therapeutics Limited?
- What is CytoMed Therapeutics Limited annual EBITDA year-on-year change?
What is CytoMed Therapeutics Limited annual EBITDA?
The current annual EBITDA of GDTC is -$2.75 M
What is the all time high annual EBITDA for CytoMed Therapeutics Limited?
CytoMed Therapeutics Limited all-time high annual EBITDA is -$1.12 M
What is CytoMed Therapeutics Limited annual EBITDA year-on-year change?
Over the past year, GDTC annual EBITDA has changed by -$859.60 K (-45.36%)